Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Toxicologic Pathology
This Article
Right arrow Free Full Text Free
Right arrow Free Full Text (Free PDF) Free
Right arrow All Versions of this Article:
0192623307312696v1
36/2/256    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Mikaelian, I.
Right arrow Articles by Wheeldon, E. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mikaelian, I.
Right arrow Articles by Wheeldon, E. B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Invited Review

Temporal Gene Expression Profiling Indicates Early Up-regulation of Interleukin-6 in Isoproterenol-induced Myocardial Necrosis in Rat

Igor Mikaelian1, Denise Coluccio1, Kevin T. Morgan2, Teona Johnson1, Amber L. Ryan1, Erik Rasmussen1, Rosemary Nicklaus1, Charu Kanwal1, Holly Hilton1, Karl Frank1, Luke Fritzky1 and Eric B. Wheeldon1

1 Hoffmann-La Roche Inc., Non-Clinical Drug Safety, Nutley, New Jersey, USA and
2 Sanofi-Aventis, Bridgewater, New Jersey, USA

Correspondence: Address correspondence to: Igor Mikaelian, Hoffmann La-Roche Inc., Non-Clinical Drug Safety, Bldg. 100/326, 340 Kingsland Street, Nutley, NJ, 07110; email: igor.mikaelian{at}roche.com.

Gene expression was evaluated in the myocardium of male Wistar rats after a single subcutaneous administration of 0.5 mg of isoproterenol, a β-adrenergic agonist that causes acute tachycardia with subsequent myocardial necrosis. Histology of the heart, clinical chemistry, and hematology were evaluated at 9 time points (0.5 hours to 14 days postinjection). Myocardial gene expression was evaluated at 4 time points (1 hour to 3 days). Contraction bands and loss of cross-striation were identified on phosphotungstic acid-hematoxylin-stained sections 0.5 hours postdosing. Plasma troponin I elevation was detected at 0.5 hours, peaked at 3 hours, and returned to baseline values at 3 days postdosing. Interleukin 6 (Il6) expression spiked at 1 to 3 hours and was followed by a short-lived, time-dependent dysregulation of its downstream targets. Concurrently and consistent with the kinetics of the histologic findings, many pathways indicative of necrosis/apoptosis (p38 mitogen-activated protein kinase [MAPK] signaling, NF-{kappa}B signaling) and adaptation to hypertension (PPAR signaling) were overrepresented at 3 hours. The 1-day and 3-day time points indicated an adaptive response, with down-regulation of the fatty acid metabolism pathway, up-regulation of the fetal gene program, and superimposed inflammation and repair at 3 days. These results suggest early involvement of Il6 in isoproterenol-induced myocardial necrosis and emphasize the value of early time points in transcriptomic studies.

Key Words: Affymetrix • gene expression • isoproterenol • interleukin 6 • myocardium • rat • transcriptomic

Abbreviations: A2m, alpha-2-macroglobulin • ABI, Applied Biosystems • Acta1, actin, alpha 1, skeletal muscle • AR, adrenergic receptor • AST, aspartate aminotransferase • Bcl2, B-cell leukemia lymphoma 2 • Cav, caveolin • Cebpb, CCAAT enhancer binding protein (C EBP), beta • CK, creatine kinase • Col5a2, procollagen, type V, alpha 2 • Crp, C-reactive protein • Egr1, early growth response 1 • Figf, c-fos induced growth factor • Gapdh, glyceraldehyde-3-phosphate dehydrogenase • Gucy1a3, guanylate cyclase 1, soluble, alpha 3 • Hand2, heart and neural crest derivatives expressed transcript 2 • HE, hematoxylin and eosin • Hif1a, hypoxia inducible factor 1, alpha subunit • Hp, haptoglobin • Il4, interleukin 4 • Il6, interleukin 6 • Il6st, interleukin 6 signal transducer • JAK STAT, Janus kinase-signal transduction and activation • Junb, Jun-B oncogene • KO, knock-out • Lbp, lipopolysaccharide binding protein • LDH, lactate dehydrogenase • MAPK, mitogen-activated protein kinase • Myh7, myosin, heavy polypeptide 7, cardiac muscle, beta • NF-kB, nuclear factor-kappa B • Nppa, natriuretic peptide precursor type A • PDGF, platelet derived growth factor • PPAR, peroxisome proliferator activated receptor • PTAH, phosphotungstic acid hematoxylin • Pygm, muscle glycogen phosphorylase • Rn18s, 18S RNA • RT-PCR, reverse transcriptase polymerase chain reaction • Socs3, suppressor of cytokine signaling 3 • Spp1, secreted phosphoprotein 1 • TGF, transforming growth factor • Tgfb, transforming growth factor • Timp1, tissue inhibitor of metalloproteinase 1 • Ucp2, uncoupling protein 2 (mitochondrial, proton carrier)

This version was published on February 1, 2008

Toxicologic Pathology, Vol. 36, No. 2, 256-264 (2008)
DOI: 10.1177/0192623307312696


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?